Join Andrea Pesce of UCSC and Laura Oliphant of Serendibite Partners talking about Investor Topics for October 19-23 DART Symposium.
Dr. Laura Oliphant is an accomplished technology executive, venture investor, and board member. She spent 25 years with Intel, 15 of which was in Intel Capital, where she received Intel’s highest award in recognition of the strategic impact of her investments. Immediately after leaving Intel, Laura served as the CEO of Translarity, an investor backed semiconductor test startup that focused on RF test applications. Laura currently serves on the Board of Directors for Novelda AS and Numascale AS, both based in Oslo, Norway. Numascale is a maker of chips that enable high performance, scale up computing, and Novelda enables presence sensing with their ultra-high-resolution radar technology. Laura is also on the boards of Aehr Test Systems (NASDAQ: AEHR), a maker of burn in systems, and Feasible, a pioneer in battery intelligence systems. In addition to her boards, she is very active in the startup community. Laura received her PhD in Chemical Engineering from the University of California, Berkeley, where her thesis research was centered on candidate batteries for electric cars.